SCHEMBL6402595

SCHEMBL6402595

Cn1c(S)nnc1-c1ccc(O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.59
NPC1 O15118 3/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
HPGD P15428 1/20 0.47
HSD11B1 P28845 4/20 0.47
SMN1; SMN2 Q16637 2/20 0.40
MAPT P10636 2/20 0.40
USP2 O75604 1/20 0.40
TP53 P04637 1/20 0.40
PKM P14618 1/20 0.40
NFKB1 P19838 1/20 0.40
RAB9A P51151 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
PTGS1 P23219 1/20 0.40
HSD17B10 Q99714 1/20 0.38
ESR1 P03372 1/20 0.37
ESR2 Q92731 1/20 0.37
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1544604 0.84 NPC1 (0.51) ALDH1A1NPC1MEN1KMT2AHPGD
SCHEMBL1544137 0.81 HSD11B1 (0.56) ALDH1A1KMT2AHSD11B1HSD17B10
SCHEMBL392037 0.81 ALDH1A1 (0.44) ALDH1A1NPC1MEN1KMT2AHPGD
SCHEMBL4184528 0.81 HSD11B1 (0.43) ALDH1A1NPC1MEN1KMT2AHPGD
SCHEMBL12803376 0.81 ALDH1A1 (0.45) ALDH1A1NPC1MEN1KMT2AHPGD
SCHEMBL392717 0.80 HSD11B1 (0.53) ALDH1A1NPC1KMT2AHSD11B1RAB9A
SCHEMBL11588544 0.79 HSD11B1 (0.48) ALDH1A1NPC1KMT2AHPGDHSD11B1
SCHEMBL17725100 0.79 HSD17B1 (0.43) ALDH1A1HPGDHSD11B1SMN1; SMN2MAPT
SCHEMBL1543914 0.78 SMN1; SMN2 (0.46) ALDH1A1MEN1KMT2AHPGDSMN1; SMN2
SCHEMBL22728158 0.78 ALDH1A1 (0.47) ALDH1A1NPC1MEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT ALDH1A1 720/4885NPC1 2070/4885MEN1 3562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.